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ReceptorDengue is transmitted primarily bymosquitoes of the Aedes genus. Despite a number of studies, no insect dengue
virus receptor protein has been clearly identiﬁed and characterized. Using a number of separationmethodologies
and virus overlay protein binding assays we identiﬁed a 35 kDa protein that segregated with susceptibility to
dengue serotype 2 (DENV-2) infection in two mosquito species and two mosquito cell lines. Mass spectroscopy
identiﬁed the protein to be prohibitin, a strongly conserved and ubiquitously expressed protein in eukaryotic
cells. Antibody mediated inhibition of infection and siRNA mediated knockdown of prohibitin expression
signiﬁcantly reduced infection levels and subsequent virus production in both Aedes aegypti and Aedes albopictus
cell lines. Confocalmicroscopy showed a signiﬁcant degree of intracellular colocalization between prohibitin and
DENV-2 E protein, and coimmunoprecipitation conﬁrmed that prohibitin interacts with dengue E. Prohibitin is
the ﬁrst characterized insect cell expressed dengue virus receptor protein.ratory, Institute of Molecular
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Dengue viruses (DENV) are the causative agent of themost common
mosquito-borne viral disease in human and are distributed over 100
countries especially in tropical and sub tropical regions (Gubler, 1997;
Guzman and Kouri, 2002). Approximately 2.5–3 billion people live in
areas potentially at risk of DENV transmission and each year there are
estimated to be 100 million new infections resulting in around 24,000
deaths, and there is still no vaccine or antiviral agent available (Guzman
and Kouri, 2002; Rigau-Perez et al., 1998). The consequences of DENV
infection in humans ranges from a self-limiting illness known as dengue
fever (DF) to a severe hemorrhagic fever (DHF) which can progress to
dengue shock syndrome (DSS) (Halstead, 1988). DENV belong to the
family Flaviviridae, genus Flavivirus. There are four antigenically related
viruses referred to as DENV-1, DENV-2, DENV-3 and DENV-4. The virion
is characterized as a small (50 nm in diameter) enveloped particle
containing a single positive sense polarity strand of RNA of approxi-
mately 11 kb in length (Chang, 1997). Themature DENV virion consists
of three structural proteins: envelope (E), capsid (C) and membrane-
associated protein (M) (Chang, 1997).
The principal vectors of DENV are mosquitoes of the Aedes genus,
predominantly Aedes aegypti and Aedes albopictus, which are wildly
distributed in both tropical and subtropical regions of the world,
particularly in Asia and America. The female mosquito obtains DENVfrom a viremic animal or human during a blood meal resulting in the
dengue viruses infecting and replicating in several mosquito tissues
and eventually the salivary gland (Gubler and Rosen, 1976). The virus
can be transmitted to eggs by vertical transmission (Diallo et al., 2000;
Fontenille et al., 1997; Rosen, 1987).
In order to infect insect host cells, DENV utilizes its envelope (E)
proteinwhichcontains the components responsible for host cell binding
and fusion (Klasse et al., 1998) to interact with host cell receptors,
followed by receptor-mediated endocytosis (Acosta et al., 2008; Mosso
et al., 2008). Numerous studies in mammalian cells have reported cell
surface receptors used by DENV to facilitate cell entry and the data
suggests that receptor usage in mammalian cells is both cell type and
serotype speciﬁc (Cabrera-Hernandez and Smith, 2005). Mammalian
receptor proteins are predominantly proteins involved in either
mediating cell: cell contacts such as DC-SIGN (Tassaneetrithep et al.,
2003) and the 37/67 kDa high afﬁnity laminin receptor (Thepparit and
Smith, 2004) or are chaperone proteins such as HSP70/90 (Reyes-del
Valle and del Angel, 2004). In contrast, no DENV insect receptor protein
has been identiﬁed, although several proteins, predominantly charac-
terized only bymolecular weight (see Table 1), have been implicated in
the virus entry process (Cao-Lormeau, 2009; Chee and AbuBakar, 2004;
Munoz et al., 1998; Sakoonwatanyoo et al., 2006; Salas-Benito and del
Angel, 1997; Yazi Mendoza et al., 2002). Signiﬁcantly, the majority of
these studies have failed to distinguishbetweendengue virus binding or
interacting proteins, of which theremay be a number in a cell, and bona
ﬁde receptor proteins in that there is no functional analysis of the role of
the identiﬁed protein in internalizing the DENV. It can be assumed that
at least some of the bands identiﬁed will represent either non-speciﬁc
binding proteins or cellular proteins such as chaperones. In an earlier
Table 1
Proposed mosquito dengue virus receptor proteins.
Cell Cell type Serotype; strain Receptor characteristics Ref.
C6/36 Aedes albopictus cell line DEN-4; H-241 Two glycoprotein 40 and 45 kDa Salas-Benito and del Angel (1997)
C6/36 Aedes albopictus cell line DEN-2; NGC 80 and 67 kDa protein Munoz et al. (1998)
C6/36 Aedes albopictus cell line DEN-2; NGC Tubulin protein or like-tubulin protein Chee and AbuBakar (2004)
C6/36 Aedes albopictus cell line DEN-3, 4 Laminin-binding protein Sakoonwatanyoo et al. (2006)
A. aegypti Midgut, ovary and salivary gland cell,
eggs, larvae and pupae cell extract
DEN-4; H-241 A 45 kDa glycoprotein Yazi Mendoza et al. (2002)
A. aegypti Salivary gland DEN-1, 2, 3 and 4 37, 54, 58 and 77 kDa protein Cao-Lormeau (2009)
A. polynesiensis Salivary gland DEN-1, 4 48, 50, 54, 56, and 77 kDa protein Cao-Lormeau (2009)
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albopictus C6/36 cells as mediating the entry of dengue serotypes 3
and 4 (Sakoonwatanyoo et al., 2006). However, whether this protein
represents a receptor actually used in insects, or is a protein that
becomes expressed as a consequence of cellular transformation or
immortalization and is capable of being used by DENV to enter cultured
cells remains unclear. As both immortalization and transformation of
cells involve both the expression of proteins not normally expressed, as
well as the down-regulation of proteins normally expressed, results on
virus entry cell culture systems need to be interpretedwith caution. In a
recent study, we showed that CCL-125 cells (an A. aegypti cell line) are
DENV permissive (Wikan et al., 2009). This study therefore sought to
determine whether there was a DENV-2 binding membrane protein
expressed by both C6/36 and CCL-125 cells, as well as by a DENV-2
susceptible mosquito species (A. aegypti) but, critically, not by a DENV
refractorymosquito species (Culex quinquefasciatus). Such a protein that
segregated with susceptibility to dengue virus would represent a
candidate dengue virus receptor protein and would be further
characterized.
Results
Investigation of DENV-2 membrane binding proteins
To investigate the DENV-2 binding proteins expressed on the
surface of C6/36, CCL-125 and adult A. aegypti mosquito cells, 100 μg
of membrane proteins of each cell type were separated on 10% SDS-
polyacrylamide gels, in parallel with membrane proteins extracted
from adult C. quinquefasciatus mosquitoes. The extracted membrane
proteins were transferred to PVDF membranes, followed by incuba-
tionwith DENV-2. Themembranes were subsequently incubatedwith
a pan speciﬁc anti-dengue virus E protein monoclonal antibody and a
secondary anti-mouse IgG conjugated with horseradish peroxidase.
As shown in Fig. 1a, a prominent binding band at approximately
35 kDa was present in C6/36, CCL-125 and adult A. aegypti mosquito
cells, but was absent from the non-dengue susceptible C. quinque-
fasciatus membrane protein preparation. The segregation of the
35 kDa band with susceptibility to dengue infection is an indication
that this protein may function as a dengue receptor protein. Several
other dengue virus binding bands were clearly observed. None of
these bands however segregated with susceptibility to infection, and
may represent non-speciﬁc binding proteins.
Characterization of a DENV-2 binding protein
To characterize the 35 kDa binding protein, two dimensional Virus
Overlay Protein Binding Assay (2D-VOPBA) was used. CCL-125 cell
membrane proteins were separated through IPG strips and 10% SDS-
polyacrylamide gels (Fig. 1b) and DENV-2 binding proteins detected
as for 1D VOPBA (above). As shown in Fig. 1c, a virus binding spot was
present at approximately 35 kDa, comparable to the result from the
1D VOPBA (Fig. 1a). The protein spot from a parallel gel was excised
and sent for protein identiﬁcation by mass spectrometry (Table 2).The MS/MS data were searched against the MSDB database using the
MASCOT search engine, the result showed that the candidate protein
is prohibitin with coverage of some 84%.
To further conﬁrm identity of the 35 kDa protein, ion-exchange
column chromatography was used fractionate the membrane proteins
before VOPBA analysis. CCL-125membrane proteinswere loaded onto a
cation-exchange column and after washing, the proteins were eluted
from the column using 2 column volume of a step gradient of cation
buffer containing NaCl concentrations of 0.1, 0.5, 0.8 and 1.0 M. The
eluted protein fractions were concentrated by TCA precipitation at 4 °C
overnight and subsequently pelleted by centrifugation. The pellets were
washed with pre-cooled acetone and ﬁnally resuspended with lysis
buffer. The proteins were loaded onto two parallel 10% SDS-polyacryl-
amide gels and the separation was carried out at constant 100 V. After
electrophoresis the proteins in one gel were transferred to PVDF
membrane and VOPBA was performed as described above, while the
parallel gelwas stainedwithCoomassie BrilliantBlue (Fig. 1d). The result
from the VOPBA analysis (Fig. 1e) showed a prominent dengue virus
binding band at 35 kDa in the lanes of crude extract (C), wash fraction
(W), 0.8 M NaCl fraction and 1.0 M NaCl fractions. Protein bands from
theparallel gelwere excised and sent formass spectroscopy analysis and
N-terminal sequencing. N-terminal sequencing of the binding protein
from the 0.8 MNaCl fraction gave no sequence, suggesting the protein is
N-terminally blocked. The remaining bandswere identiﬁed as prohibitin
with peptide coverages of 59% (from crude fraction; Table 2), and 58%
(from wash fraction; Table 2). The third band from the 1.0 M NaCl
fraction did not have prohibitin as a major candidate, but had peaks
present in the peak list that corresponded to some 22% coverage of
prohibitin. The lack of a clear identiﬁcation of prohibitin in the 1.0 M
NaCl fraction might indicate a large number of similarly sized proteins
eluting at this molarity. Overall however, the 35 kDa DENV-2 binding
band was therefore identiﬁed as prohibitin in four separate analyses,
with isolation by two independent methodologies.
Prohibitin is composed of 2 proteins, with molecular weights of
~30 kDa (prohibitin 1 or PHB1) and ~37 kDa (prohibitin 2 or PHB2)
which share more than 50% amino-acid identity (Mishra et al., 2006).
The two proteins function together as hetero-oligomers which is
required for protein stability, and loss of one prohibitin protein in the
cell leads to loss of the other protein (Artal-Sanz et al., 2003; Berger and
Yaffe, 1998; He et al., 2008; Kasashima et al., 2008; Merkwirth et al.,
2008), and this is controlled at the level of the protein, and is
independent of RNA levels (Kasashima et al., 2006). While the mass
spectroscopy results didnot allowunambiguousdifferentiationbetween
prohibitin 1 and prohibitin 2, our results are consistent with dengue
binding to prohibitin 2, given the largermolecularweight of this protein.
The role of prohibitin in DENV-2 infection
To investigate the role of prohibitin in dengue virus infection,
siRNA mediated-gene silencing was utilized. Attempts were initially
undertaken to directly down-regulate prohibitin 2 but, despite
extensive attempts, the prohibitin 2 message proved refractory to
silencing. The reasons for some mRNAs being refractory to silencing
Fig. 1. VOPBA analysis of DENV-2 binding to insect cell membrane proteins. (a) Membrane proteins from C6/36 cell (lane 1), CCL-125 cell (lane 2), whole adult Aedes aegypti (lane 3)
and whole adult Culex quinquefasciatus (lane 4) were subjected to 10% SDS-PAGE and transferred to PVDF membranes. Virus overlay was used to detect the position of DENV-2
binding proteins. A prominent DENV-2 binding band that segregated according to DENV-2 susceptibility was present at approximately 35 kDa (black arrow). (b and c) CCL-125
membrane proteins were extracted and subjected to ﬁrst dimension isoelectric focusing on 7 cm IPG (pH 3–10) strips and second dimension 10% SDS-PAGE. One of two parallel gels
was stained with Coomasie Brilliant Blue R-250 (b), and the second was transferred to a PVDFmembrane and the position of dengue virus binding spots determined by virus overlay
(c). A virus binding spot was present at approximately 35 kDa (arrows, b, c). The corresponding spot on the parallel Coomasie stained gel was excised and analyzed by mass
spectrometry. (d,e) CCL-125 membrane proteins were fractionated by cation-exchange chromatography with elution at the indicated NaCl concentrations. Samples were
concentrated and run on two parallel gels (d, e) together with un-fractionated crude extract (lane c) and the eluted wash fraction (lane w). One gel was stained Coomasie Brilliant
Blue R-250 (d) while the second was transferred to solid matrix support before detection of dengue virus binding bands (e). The 35 kDa band (e, arrowed) from crude, wash and
1.0 M NaCl were excised from the parallel Coomasie Brilliant Blue R-250 stained gel and subjected to mass spectroscopy analysis.
151A. Kuadkitkan et al. / Virology 406 (2010) 149–161are unclear, but probably relate to the formation of stable secondary
structures in the mRNA (Kurreck, 2006). However, given that stability
of prohibitin 2 protein requires the presence of prohibitin 1 protein
(Artal-Sanz et al., 2003; Berger and Yaffe, 1998; He et al., 2008;
Kasashima et al., 2008; Merkwirth et al., 2008), silencing of prohibitin
1 at the mRNA level would functionally silence prohibitin 2 at the
protein level.To down-regulate the expression of PHB1 in C6/36 and CCL-125
cells, each cell type was transfected with 500 pmol of siPHB1_3 in
parallel with lipofectamine alone (mock transfection). The cells were
harvested for RNA extraction every day for 5 days post-transfection
(p.t.). Multiplex PCR was performed to detect the expression level of
PHB1 and PHB2 concurrently, and the results were analyzed by
agarose gel electrophoresis. As the interdependence of prohibitin is
Table 2
Results of Mascot searches of peak lists generated from MS/MS analysis. In each case the top 4 results are shown.
Accession number Mass Score Expected value Matching peptides Description
2D VOPBA band
gi 157122974 29885 806 7.5 e−76 29 Prohibitin (Aedes aegypti)
gi 167865262 29788 513 1.5 e−46 19 Prohibitin-like protein (Culex pipens quinquefasciatus)
gi 167865263 29774 513 1.5 e−46 19 Prohibitin-like protein (Culex pipens quinquefasciatus)
gi 158288134 30081 475 9.4 e−43 16 Prohibitin-like protein (Anopheles gambiae)
Column chromatography (crude fraction)
gi 157131969 32969 383 1.5 e−33 21 Prohibitin (Aedes aegypti)
gi 157131971 33071 383 1.5 e−33 21 Prohibitin (Aedes aegypti)
gi 157131967 38776 381 2.4 e−33 22 Prohibitin (Aedes aegypti)
gi 157111500 30106 230 3 e−18 31 40S ribosomal protein S3a (Aedes aegypti)
Column chromatography (wash fraction)
gi 157131969 32969 301 2.4 e−25 23 Prohibitin (Aedes aegypti)
gi 157131971 33071 301 2.4 e−25 23 Prohibitin (Aedes aegypti)
gi 157131967 38776 294 1.2 e−24 23 Prohibitin (Aedes aegypti)
gi 158298506 38457 160 3.0 e−11 16 Prohibitin-like protein (Anopheles gambiae)
Column chromatography (1 M fraction)⁎
gi 157111500 30106 462 1.9 e−41 42 40S ribosomal protein S3a (Aedes aegypti)
gi 157111502 25352 401 2.4 e−35 39 40S ribosomal protein S3a (Aedes aegypti)
gi 170045145 41357 266 7.6 e−22 29 40S ribosomal protein S3a (Aedes aegypti)
gi 109290382 17643 220 3.0 e−17 17 40S ribosomal protein S3a (Culex pipens quinquefasciatus)
⁎ Peptide masses consistent with prohibitin were present as a minor constituent in this sample, corresponding to 22% protein coverage.
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al., 2003; Berger and Yaffe, 1998; Kasashima et al., 2006) PHB2 mRNA
level was used as an internal control in silencing PHB1. Results (Fig. 2)
showed a constant signal for PHB1 and PHB2 inmock transfected cells
while a signiﬁcant reduction in the level of PHB1 mRNAwas observed
in response to transfection with siPHB1_3 by days 3 to 5 p.t. and the
greatest reduction was observed on day 4 p.t., which was selected as
the optimal time point for subsequent experiments.
CCL-125 cells were transfected with siPHB1_3 as described above,
as well as with siGFP as a siRNA control as well as mock infected with
lipofectamine alone. On day 4 post-transfection, cells were harvested
and proteins extracted which were then separated by electrophoresis
through a 10% polyacrylamide gel and transferred to solid matrix
support following which membranes were probed with anti-human
prohibitin 1 and anti-human prohibitin 2 antibodies as well as actin as
an internal control. While the anti-human prohibitin 1 antibody was
speciﬁc for prohibitin 1 in CCL-125 cells, the anti-human prohibitin 2
antibody cross reacted with both prohibitin 1 and 2 and showed a
slightly higher afﬁnity for prohibitin 1 (Fig. 2b). However, reduction in
the expression of both prohibitin 1 and prohibitin 2 was observed in
the siPHB1_3 transfected cells, while no reduction was seen in normal
control, mock transfected or siGFP transfected cells (Fig. 2b).
CCL-125 and C6/36 cells were mock transfected and transfected
with both siPHB1_3 and siGFP as above and on day 4 post-transfection
were infected with DENV-2. Given that the times for de novo DENV-2
production are different for infected C6/36 and CCL-125 cells, namely
17 h for DENV-2 from C6/36 cells (Sakoonwatanyoo et al., 2006) and
20 h for DENV-2 from CCL-125 cells (Wikan et al., 2009), infected cells
were cultured for one and a half virus replication cycle for each cell
type (25.5 h post-infection for C6/36 cells and 30 h for CCL-125 cells)
which maximizes virus output but ensures that the virus produced
comes only from the initial round of infection. Subsequently the cells
were harvested for protein extraction and Western blot analysis,
while the culture medium was collected for standard plaque assay.
The result of western blot assay showed a reduction of PHB1 in CCL-
125 cells and a reduction of PHB2 in both C6/36 and CCL-125 (Fig. 3a)
cells. Interestingly the antibody used failed to detect prohibitin 1 in
C6/36 cells (data not shown), but given that this antibody is an anti-
human prohibitin antibody this is perhaps not unsurprising. In the
VOPBA analysis, the result showed a decrease in DENV-2 binding in
the siPHB1_3 treated samples as compared to the siGFP or mock
transfected samples (Fig. 3a) conﬁrming that prohibitin is, at least, a
DENV-2 binding protein and that it is prohibitin 2, and not prohibitin1 that binds DENV-2. The levels of reduction of prohibitin expression
in both siPHB treated C6/36 (approximately 50%) and CCL-125 cells
(approximately 60%) were equal to the reduction seen in the VOPBA
analysis (Fig. 3b). Extracellular virus production was signiﬁcantly
decreased by approximately 90% in both CCL-125 and C6/36 cells
treated with siPHB1_3 (Figs. 3c, d) compared to both siGFP and mock
transfected cells.
Antibody mediated inhibition of DENV-2 entry
To more precisely deﬁne the role of prohibitin in mediating DENV-
2 internalization, C6/36 and CCL-125 cells were pre-incubated with
various amounts of a polyclonal anti-PHB2 antibody (sc-67045, Santa
Cruz Biotechnology) or no antibody or a control polyclonal antibody
against STAT5 (sc-28685, Santa Cruz Biotechnology) before infection
with DENV-2 as described above. The anti-STAT5 antibody was
selected as both it and the anti-PHB2 antibody are rabbit polyclonal
antibodies. The infected cells were again cultured for one and a half
virus replication cycles of each cell type (25.5 h post-infection for C6/
36 cells and 30 h for CCL-125 cells) and the culture medium and the
cells were collected separately for assay of viral extracellular and
intracellular virus levels, respectively. The experiments were done
independently in triplicate, with duplicate plaque assay. Intracellular
virus levels showed a signiﬁcant difference between prohibitin
antibody treated cells and controls in both cell types (Figs. 4a, b)
with a reduction of approximately 90%, similar to the reduction seen
in the silencing experiments. Similar to intracellular virus level,
extracellular virus levels show a signiﬁcant decrease of viral
production in antibody pre-treated cells (Figs. 4c,d), although while
C6/36 cells showed a reduction of 90% consistent with the silencing
experiments, CCL-125 cells showed a slightly smaller reduction of
only 75%. The results strongly suggest that PHB2 act as a DENV-2
receptor present on the surface of both cell types. Moreover as both
down-regulation of prohibitin through siRNA and blocking of cell
surface expressed prohibitin with an antibody produce approximately
90% reductions in both virus output and intracellular virus levels
(with the exception of antibody inhibition of CCL-125 cells on virus
output) the results would suggest that the major contribution of
prohibitin is as a receptor protein as opposed to a chaperone protein.
The inhibition of infection of DENV-2 in the presence of anti-PHB
antibodies as well as the speciﬁcity of prohibitin for dengue was
conﬁrmed by ﬂow cytometry. C6/36 cells were pre-incubated with
antibodies directed against PHB2, integrin αV/β5 or no antibody
Fig. 2. siRNAmediated-gene silencingofprohibitin. (a) CCL-125 cellswere transfectedwith siPHB1_3 to silenceprohibitin1 geneexpression.Multiplex PCRproducts of PHB1(upper band)
and PHB2 (lower band) from mock and siPHB1_3 transfected cells are shown for days 1 to 5 post-transfection. M: 100 bp ladder. (b) CCL-125 cells were not treated (Normal Ctr),
transfected with siPHB1_3 or siGFP or mock transfected for 4 days before analysis of levels of prohibitin 1 and 2 byWestern blotting. Filters were subsequently probedwith an anti-actin
antibody. A cross reacting PHB1 band is indicated (*). A bar graph of intensity of PHB1 (gray bars) and PHB2 (cross-hatched bars) after normalization against actin is shown.
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antibody before infectionwith JEV at MOI 10. After incubation for 15 h
for JEV infected cells or 16 h for DENV-2 infected cells, cells were
subjected to ﬂow cytometry after staining with primary antibodies
directed against dengue E protein or an antibody speciﬁc for ﬂavivirus
E proteins. Results (Fig. 5) showed that anti-PHB2 antibodies
speciﬁcally reduced the number of infected cells by approximately
50% while not affecting JEV entry.
To provide further evidence that PHB acts as a receptor protein, we
investigated binding of DENV-2 to C6/36 cells in the presence or
absence of anti-PHB2 antibodies. C6/36 cells were either pre-treated
with a rabbit polyclonal antibody directed against PHB2 or not pre-
treated before incubationwithDENV-2ormock infection. All stepswere
undertaken at 4 °C. DENV-2 was visualized by successive incubations
with a pan speciﬁc anti-dengueEproteinmonoclonal antibody followed
by a FITC conjugated secondary antibody and observation under a
ﬂuorescent microscope. Results showed a considerable reduction of
DENV-2 binding when cells were pre-treated with the anti-PHB
antibody as compared to non-treated cells (Fig. 6), conﬁrming that
DENV-2 binds to PHBat the cell surface and that blocking of PHB2 blocks
attachment of the virus.
Intracellular colocalization between prohibitin and DENV-2 E protein
To determine whether there is an intracellular interaction between
prohibitin andDENV-2 Eprotein, C6/36 cellswere seededonglass cover
slips and infected with DENV-2 in parallel with mock infected cells. At
24 h post-infection, the cells were ﬁxed with pre-cooled methanol and
then permeabilized with 0.3% Triton X-100 in PBS. Subsequently the
cells were incubated with an anti-dengue virus E protein monoclonalantibody and a goat polyclonal anti-PHB antibodyor anti-denguevirus E
protein monoclonal antibody and a rabbit polyclonal anti-PHB2
antibody followed by the appropriate secondary antibody conjugated
withﬂuorescencedyes. The results (Fig. 7) showcolocalization between
both DENV-2 and PHB1 and DENV-2 and PHB2.
Intracellular interaction between prohibitin and dengue E protein
Todemonstrate a direct interaction betweenprohibitin andDENV-2,
coimmunoprecipitation experiments were undertaken. C6/36 cells
were either infected with DENV-2 or mock infected and at 3 days
post-infection cells were harvested and lysed before incubation with a
protein G sepharose slurry to remove non-speciﬁc binding proteins,
followed by the addition of a rabbit polyclonal anti-PHB2 antibody and
subsequently a second round of protein G sepharose slurry, before
coimmunoprecipitated proteinswere runon a polyacrylamide gel. After
electrophoresis, proteinswere transferred to solid matrix together with
crude lysate fractions, and dengue E protein was detected with a
monoclonal antibody. Results (Fig. 7c) showed that dengue E protein
was coimmunoprecipitated together with prohibitin.
Discussion
Todate only two studies have reported thepartial characterizationof
putative DENV receptor proteins expressed by C6/36 cells (an A.
albopictus cell line). In 2004, using VOPBA coupled with mass
spectrometric analysis Chee and AbuBakar (2004) identiﬁed a 48 kDa
tubulin-like protein able to bind DENV-2. However a DENV-2 binding
band was found only in the cytosolic protein fraction and not in
membrane fraction of C6/36 cells. It is possible therefore that tubulin
Fig. 3. DENV-2 infection of prohibitin silenced insect cells. (a) Membrane proteins from control or prohibitin silenced DENV-2 infected C6/36 or CCL-125 cells were subjected to 10%
SDS-PAGE and transferred to PVDFmembranes before virus overlay. Filters were subsequently stripped and analyzed for levels of prohibitin 1, prohibitin 2 and actin. A cross reacting
PHB1 band is indicated (*). Intensity of prohibitin 2 (gray bars) and VOPBA band (cross-hatched bars) was determined by densitometry and is plotted after normalization against
actin (b). Virus production frommock transfected, siGFP transfected and siPHB1_3 transfected C6/36 (c) or CCL-125 cells (d) infected with DENV-2. Virus yield is shown at one and a
half DENV-2 replication cycles post-infection and plotted as virus titer (PFU/ml)±SD. The experiments were undertaken independently in triplicate with duplicate plaque assays.
The statistical signiﬁcance of virus output compared with the mock transfected cells is shown. *Signiﬁes Pb0.001 as compared to mock transfected cells.
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initial binding. Using western blot, VOPBA analysis and an inhibition of
infection assay, we have previously shown evidence that a laminin
binding protein is a candidate DENV-3 and DENV-4 receptor protein
(Sakoonwatanyoo et al., 2006).
In this study, again using VOPBA analysis, we found a prominent
DENV-2 binding band at approximately 35 kDa that was observed in
membrane proteins from C6/36 and CCL-125 cells and from adult A.
aegypti mosquitoes, but critically, was not present in membrane
proteins from adult C. quinquefasciatus, a non-susceptible species.
While one report has shown that C. quinquefasciatus can be infected
with DENV-2 (Vazeille-Falcoz et al., 1999), this was only obtained using
intrathoracic injection of extremely high titers of DENV-2 and no
infection was observed when C. quinquefasciatus mosquitoes were
exposed orally to DENV-2 under conditions in which 100% of A. aegypti
mosquitoes became infected. This would be consistent with other
authors who have shown C. quinquefasciatus to be a non-susceptible
species to dengue infection (Huang et al., 1992). Overall, while the
evidence suggests that C. quinquefasciatus maybe infected under
conditions of exposure to extremely high virus titers, it is unlikely to
play a role as a dengue vector, and our use of this species as a non-
susceptible species is not unwarranted.As such, the 35 kDa protein segregateswith susceptibility toDENV-2
infection, suggesting it is a viable candidate for a receptor protein.
Interestingly, the band we previously identiﬁed as a laminin binding
protein (Sakoonwatanyoo et al., 2006) was present in all membrane
extracts, and indeed, a number of non-speciﬁc binding bands were
present in the range 55 to 200 kDa (Fig. 1). While the 35 kDa protein
band identiﬁed in our study is distinct from proteins that have been
implicated previously by ourselves (Sakoonwatanyoo et al., 2006) or by
other groups (Chee and AbuBakar, 2004; Munoz et al., 1998; Salas-
Benito et al., 2007; Salas-Benito anddel Angel, 1997;YaziMendozaet al.,
2002) and as such represents a novel candidate, evidence for a 35–
37 kDa DENV binding protein in A. aegypti insect tissues is seen in the
VOPBA analysis of at least two other groups (Cao-Lormeau, 2009; Yazi
Mendoza et al., 2002).
In our VOPBA analysis, we clearly detected the 40/45 kDa DENV
binding protein previously reported as putative DENV-4 receptor
(Reyes-del Valle and del Angel, 2004; Salas-Benito and del Angel,
1997) in C6/36 and CCL-125 membrane proteins, however these
protein bands were not present in our preparations of membrane
proteins from adult A. aegyptimosquitoes (Fig. 1). It is possible that as
C6/36 and CCL-125 cells are derived from mosquito larvae different
receptor proteins are expressed at different stages of maturity.
Fig. 4. Antibody mediated inhibition of infection assessed by plaque assay. C6/36 (a, c) and CCL-125 (b, d) cells were pre-treated for 1 h with an antibody directed against prohibitin
2 (at different concentrations) or STAT5 as control or with no antibody before infection with DENV-2 and both intracellular (a, b) and extracellular (c, d) virus production determined
by standard plaque assay. Virus yield is plotted as virus titer±SD. The experiments were undertaken independently in triplicate with duplicate plaque assays. The statistical
signiﬁcance of virus output compared with the control (no antibody) is shown. a*, Pb0.001; b*, P=0.001, c*, P=0.005.
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receptor protein after isolation by two independent techniques
identiﬁed the candidate protein as prohibitin. Prohibitin (PHB) is a
ubiquitously expressed and highly conserved protein in eukaryotic cells
(Morrow and Parton, 2005). Initial investigations of PHB showed that
this proteinacted as an inhibitor of cell proliferation andhence thename
prohibitin (McClung et al., 1989). Prohibitin is composed of 2 proteins
with different molecular weights. Prohibitin1 (PHB1) has a mass of
~30 kDawhile prohibitin2 (PHB2) has a mass of ~37 kDa (Mishra et al.,
2006). PHB1 and PHB2 are highly homologous to each other and share
more than50% identical amino-acid residues (Mishra et al., 2006). These
two proteins have a propensity to form oligomers and hetero-
oligomerization has been proposed to be required for the stability of
the proteins. The loss of PHB1 protein leads to the loss of PHB2, and vice
versa (Artal-Sanz et al., 2003; Berger and Yaffe, 1998; He et al., 2008;
Kasashima et al., 2008; Merkwirth et al., 2008). However, this
interdependence of PHB is found at the level of the protein, and not at
the level of the RNA (Kasashima et al., 2006). PHB is present in many
compartments of the cell, mainly themitochondria (Ikonen et al., 1995;
Merkwirth and Langer, 2009;Nijtmans et al., 2000) but is also present in
the cytoplasmandnucleus (Thompsonet al., 2001;Wanget al., 2002). In
2004, Sharma and Qadri (Sharma and Qadri, 2004) reported that the Vi
capsular polysaccharide of Salmonella typhi can bind to PHB on a human
intestinal epithelial cell membrane resulting in S. typhi resistance to
phagocytosis and attenuation of IL-8 production via theMAPK pathway.
In the same year Kolonin et al. (2004) identiﬁed a peptide motif which
binds to PHBon thewhite fat vasculature ofmice. Collectively these two
studies indicate that PHBcan function asa cell surfaceexpressedbinding
protein.Previous studies have also elucidated a chaparonin function for
prohibitins in mitochondria (Nijtmans et al., 2000, 2002). As such, the
reduction of DENV-2 production seen in prohibitin silenced cells could
reﬂect the reduction of chaperone activity of PHB, and indeed,
colocalization analysis suggested that there is a signiﬁcant intracel-
lular interaction between prohibitin and dengue E protein, and this
was conﬁrmed by coimmunoprecipitation experiments, providing
conﬁrmation of a physical interaction between dengue E protein and
prohibitin. Pertinently however, DENV-2 entry was signiﬁcantly
reduced in the presence of anti-prohibitin antibodies, suggesting a
direct interaction at the cell surface, which is supported by the
reduction of DENV-2 binding to cells pre-treated with anti-prohibitin
antibodies. The possibility of multiple interactions between DENV
receptor proteins and DENV proteins does however have precedents.
We have previously identiﬁed the chaperone protein (GRP78) as a
DENV-2 receptor protein in liver cells (Jindadamrongwech et al.,
2004) and more recently the GRP78 has been implicated as a direct
DENV E protein chaperone in various cell types (Wati et al., 2009).
Given the multifunctional nature of many cellular proteins, it is
perhaps not unsurprising that viruses can interact with particular
proteins at multiple stages in its replication cycle.
Wehave shownhere thatDENV-2 interactswithAedesprohibitin but
not Culex prohibitin, and moreover that the interaction is speciﬁc for
DENV-2 and not for a closely related ﬂavivirus, Japanese encephalitis
virus despite prohibitin being a highly conserved protein. As noted
previously, oligomerized PHB1/PHB2 proteins are believed to form ring
structures (Ikonen et al., 1995;Merkwirth and Langer, 2009;Nijtmans et
al., 2000)with a diameter of 20 to 25 nm.The regular arrangementof the
PHB1/PHB2 heterodimers around the ring provides the possibility of
Fig. 5. Antibody mediated inhibition of infection assessed by ﬂow cytometry. C6/36 cells were pre-treated with antibodies against integrin αV/β5 or PHB2 or no antibody (a, c)
before infection with DENV-2 at MOI of 10, or treated with antibodies against STAT5 or PHB2 or no antibody (b, d) before infection with JEV at MOI of 10. After 15 (JEV) or 16 (DENV-
2) hours percent infection was determined by ﬂow cytometry. Raw data proﬁles (a, c) and tabular analysis (b, d) from three independent experiments are shown.
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the DENV virion possibly sitting in the space in the ring. As the dengue
virion is composed ofmultiple E subunits (Khun et al., 2002) it is possible
that individual E proteins in the virion could interact with individual
PHB1/PHB2 heterodimers. In thisway species and virus speciﬁcity could
be modulated by relatively small changes in the highly conserved
prohibitin protein. In this way, the small number of non-conserved
amino-acid residues between PHB2 from A. aegypti and C. quinquefas-
ciatus may be the primary mediators of virus speciﬁcity. The highFig. 6. Analysis of DENV-2 binding to C6/36 cells. C6/36 cells were either mock infected (Mo
against PHB2 (DENV-2+anti-PHB Ab) at 4 °C. Samples were subsequently incubated with a
antibody before visualization under a ﬂuorescence microscope.conservation of PHB enabled the use of anti-human PHB antibodies in
the experiments here. While the respective anti-human PHB polyclonal
antibodies are speciﬁc for human PHB1 and PHB2, we observed cross
reactivitywith the anti-human PHB2 polyclonal antibody detecting both
PHB1 and PHB2 from both A. albopictus and A. aegypti, while the anti-
human PHB1 antibody did not detect A. albopictus PHB1. A. aegypti and
human prohibitins are approximately 75% homologous (both PHB1 and
PHB2), and as noted previously human PHB1 and PHB2 share 50%
amino-acid identity (Mishra et al., 2006). Differences in cross reactivityck) or infected with DENV-2 in the absence (DEN-2) or presence of antibodies directed
monoclonal directed against dengue E protein (HB114) and an appropriate secondary
Fig. 7. Interaction of prohibitin with DENV-2 E protein. (a, b) C6/36 cells were grown on glass cover slips and either mock infected or infected with DENV-2 and examined for the
localization of PHB1 (a; red) or PHB2 (b; red) and DENV-2 E protein (green). Fluorescent signals were observed using an Olympus FluoView 1000 confocal microscope.
Representative, non-contrast adjusted unmerged and merged images are shown. Merged images have bright-ﬁeld view added. (c) C6/36 cells were either mock infected or infected
with DENV-2 for 3 days after which cells were lysed. Lysates were either analyzed directly or after coimmunoprecipitation using an anti-PHB2 polyclonal antibody for the presence of
DENV-2 E protein.
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aegypti and A. albopictus may also explain the somewhat unequal
inhibition seen between C6/36 and CCL-125 cells when the antibody isused to block virus entry. Until the development of speciﬁc antibodies
against insect prohibitins, research in this area will still need to use the
sub-optimal anti-human monoclonal antibodies.
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expressed DENV-2 receptor protein, prohibitin. It is clear however that
prohibitin interacts with DENV-2 at several points in its life cycle, and
our identiﬁcation of prohibitin as a receptor protein relies primarily
upon the signiﬁcant levels of antibody mediated inhibition of infection
seen in the presence of anti-prohibitin antibodies, and this was
conﬁrmed by two different methodologies. The gold standard of
receptor identiﬁcation is using the identiﬁed receptor protein to make
a non-permissive cell line permissive. However, in the absence of a well
characterized dengue non-permissive cell line this becomes problem-
atic. In addition, prohibitin acts as a complex and, to obtain permissive-
ness to dengue in a non-permissive cell line, it would probably be
necessary to drive expression of both PHB1 and PHB2 over endogenous
prohibitin expression. Further, more detailed studies will be required to
dissect out the contributions of prohibitin at different stages of the
dengue virus life cycle. At this point in time we have only characterized
the interaction with DENV-2, and as such further studies will seek to
determine if this protein is used by other dengue serotypes. As a highly
conserved and ubiquitous protein, it is also possible that this protein
interacts with DENV in infections in mammalian cells, which would
point towards conserved pathways in DENV replication in insect and
mammalian cells.
Material and methods
Cell culture and virus stocks and titration
Dengue virus serotype 2 (strain 16681) was propagated in C6/36
cells as described elsewhere (Sakoonwatanyoo et al., 2006). Japanese
encephalitis virus (Beijing-1strain, accession No. L48961) was propa-
gated as described previously (Boonsanay and Smith, 2007). C6/36 cells
were cultured at 28 °C in minimum essential medium (MEM, Gibco™
Invitrogen, Carlsbad, California, USA) supplemented with 10% heat-
inactivated fetal bovine serum (FBS, Gibco™ Invitrogen) and 100 U/ml
of penicillin and 100 μg/ml streptomycin (PAA Laboratories, Linz,
Austria). CCL-125 cells were cultured at 28 °C in L-15 medium
(Leibovitz's L-15 medium, Gibco™ Invitrogen) supplemented with
20% ΔFBS, 100 U/ml penicillin and 100 μg/ml streptomycin. LLC-MK2
cells were cultured at 37 °C/5% CO2 in Dulbecco's modiﬁed Eagle's
medium (DMEM, Gibco™ Invitrogen) supplemented with 10% ΔFBS,
100 U/ml penicillin and 100 μg/ml streptomycin. All work with DENV
infected cells was undertaken under BSL2 containment. Plaque assays
were undertaken as previously described (Sithisarn et al., 2003).
Mosquitoes
The two species of mosquitoes, A. aegypti (Linnaeus) and C.
quinquefasciatus (Say), were laboratory-reared and maintained at
28 °C until adults. The A. aegypti mosquitoes were from a colony
originally established by the Department of Medical Sciences, National
Institute of Health, Thailand from eggs collected in Bangkok, Thailand in
1989 and laboratory-reared since then. The C. quinquefasciatus
mosquitoes were from a colony originally established by the Depart-
ment of Medical Sciences, National Institute of Health, Thailand from
immature stages (larvae/pupae) collected in Bangkok, Thailand in 1978
and laboratory-reared since then.
C6/36 and CCL-125 cell membrane protein preparation
Cell membrane preparations were undertaken as previously
described (Thepparit and Smith, 2004). Brieﬂy, twenty 100×20-mm
culture plates of conﬂuent C6/36 or CCL-125 cells were washed twice
with Tris-buffered saline (TBS, 50 mMTris–HCl [pH 7.6], 150 mMNaCl).
The cells were then collected by scraping and pelleted by centrifugation
at 610×g for 3 min followed by resuspension in pre-cooled lysis buffer
(Buffer SF, 0.5% Triton X-100, 60 mM DTT, 2 mM PMSF). The cells werelysed by vortexing and sonicating at 4 °C. The solution was centrifuged
at 610×g to remove cell debris. The supernatant was transferred into a
new tube. The pellets were lysed again until no intact cells remained.
The supernatants were pooled and centrifuged at 6000×g for 5 min to
remove membranous organelles and then at 20,800×g for 10 min to
pellet the plasma membrane proteins. The pellet was resuspended in
buffer SF and protein concentration was determined by the Bradford
assay (Bradford, 1976). The proteins were kept at−80 °C until used.
Mosquito membrane preparation (whole insects)
Pooled adult mosquitoes (1.5–2 g) were ground in liquid nitrogen
and then suspended in pre-cooled lysis buffer (Buffer II, 20 mMTris–HCl
[pH 7.5], 300 mM NaCl, 1 mM EDTA, 1% Triton X-100, 2 mM PMSF).
Subsequentmembrane protein extraction was undertaken as described
above.
Western blotting and virus overlay protein binding assay (VOPBA)
Approximately 100 μg of membrane proteins from C6/36 cells, CCL-
125 cells, A. aegypti and C. quinquefasciatusmosquitoes were separated
by electrophoresis through 10% SDS-polyacrylamide gels and proteins
were transferred to solid matrix support (PVDF membranes) using the
Mini Trans-blot Electrophoretic Transfer Cell (Bio-Rad Laboratories,
Richmond, CA). The membranes containing transferred proteins were
blockedwith5% skimmilk in TBSbuffer for 2 h at roomtemperature. For
Western blotting, themembraneswere incubatedwith a 1:500 dilution
of a goat polyclonal anti-prohibitin 1 (PHB1) antibody (sc-18196, Santa
Cruz Biotechnology, Santa Cruz, CA) or a 1:500 dilution of a rabbit
polyclonal anti-PHB2 antibody (sc-67045, Santa Cruz Biotechnology) or
a 1:500 dilution of a goat polyclonal anti-actin antibody (sc-1616, Santa
Cruz Biotechnology) at room temperature for 4 h. Themembraneswere
then incubated with a 1:3000 dilution of a horseradish peroxidase-
conjugated rabbit anti-goat IgG (31402, Pierce, Rockford, Ill, USA) or a
1:4000 dilution of a horseradish peroxidase-conjugated goat anti-rabbit
IgG (31460, Pierce) at room temperature for 1 h. Finally, the signals
were developed by using the ECL Plus™ Western blotting analysis kit
(Amersham Bioscience, NJ, USA), followed by autoradiography. For
VOPBA, themembraneswere incubatedwith 108 PFU of DENV-2 at 4 °C
over night. After three washes with TBS buffer, the membrane was
further incubated with a 1:100 dilution of a pan speciﬁc anti-dengue
virus E protein monoclonal antibody, produced by hybridoma cell line
HB114 (Henchal et al., 1982), in 5% skim milk in TBS buffer for 2 h at
room temperature. Then themembranes were incubatedwith a 1:8000
dilution of a horseradish peroxidase-conjugated rabbit anti-mouse IgG
secondary antibody (Sigma Chemical Co., St. Louise, MO, USA) in 5%
skim milk in TBS buffer for 1 h at room temperature. The signal was
developed as described above.
Two-dimensional virus overlay protein binding assay
Membrane proteins of CCL-125 cells were prepared for 2 dimen-
sional gel electrophoresis using the 2-D Sample Prep for Membrane
Proteins kit (Pierce, Rockford, Ill, USA) according to the manufacturer's
instruction. Then 150 μg of membrane proteins were loaded on IPG
strips (Immobiline™DryStrip pH3–10 NL, 7 cm, AmershamBioscience)
and the rehydration step was performed at 50 μA for 15 h using the
IPGphor IEF system (Amersham Bioscience). Subsequently, IEF was
carried out for 30 min at 300 V, 30 min at 1000 V and 2 h at 5000 Vwith
a step-and-hold gradient until it reached to 8000 volt-hours. The strips
were equilibrated with 5 ml of equilibration buffer (2% SDS, 50 mM
Tris–HCl [pH 8.8], 6 M urea, 30% glycerol, 0.002% bromophenol blue)
containing 50 mg of dithiothreitol (DTT) for 15 min at room temper-
ature followed with 5 ml of equilibration buffer containing 125 mg of
iodoacetamide for 15 min at room temperature. The equilibrated strips
were placed on the top surface of a 10% SDS-polyacrylamide gel.
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rad)were applied to small pieces of chromatographypaper and inserted
next to each strip on the top of the gel, then the strips and marker were
sealed with hot sealant (0.5% agarose in 1× SDS-PAGE running Buffer,
0.001% Bromophenol blue). The second dimension was carried out at a
constant 100 V. The gels were stained with Coomasie Brilliant Blue R-
250 or transferred to PVDF membranes for VOPBA with DENV-2 as
described above.
Ion-exchange column chromatography and virus overlay protein binding
assay
Membrane proteins from CCL-125 cells (1.5 mg) prepared as
described above were applied onto cation-exchange chromatography
columns (Macro-prep High S Support, Bio-Rad Laboratories). The
columns were washed with two column volumes of NaCl-free cation
buffer (20 mM Na2HPO4) and then proteins were eluted with two
column volumes of cation buffer containing 0.1, 0.5, 0.8, 1.0 M NaCl
respectively. Trichloroacetic acid (TCA; Sigma Chemical Co.) was
added to eluted fractions to precipitate proteins and samples were
incubated at 4 °C overnight. Solutions were centrifuged at 15,000×g
for 15 min at 4 °C. The pellets were washed with pre-cooled acetone
and then centrifuged at 15,000×g for 15 min at 4 °C. After the
supernatant was removed, the proteins were resolubilized in lysis
buffer and divided into 2 aliquots for SDS-PAGE separation. One gel
was stained with Coomasie Brilliant Blue R-250 and the other was
transferred to solid matrix support and analyzed by VOPBA with
DENV-2 as described above.
Peptide mass ﬁngerprint analysis (PMF)
Peptide mass ﬁngerprint analysis was used to further identify
DENV-2 binding proteins. Protein bands or spots that corresponded to
the VOPBA result were excised from the gel and sent to the Australian
Proteome Analysis Facility (APAF, Macquarie University, Australia) for
mass spectrometry analysis.
siRNA design and generation
The target site on A. aegypti PHB 1 (GenBank accession number
XM_001653742.1) and the green ﬂuorescent protein (GFP: GenBank
accession number U50974) were determined using the online tool
from Ambion, Austin, TX (http://www.ambion.com/techlib/misc/
siRNA_ﬁnder.html). The sequences were subjected to siRNA template
design to generate DNA oligonucleotide sequences for use for




siRNAs were synthesized using the Silencer® siRNA construction
Kit (Ambion, Austin, TX, USA) based on in vitro transcription and the
concentrations were determined by spectrophotometry.
siRNA transfection
The CCL-125 or C6/36 cells weremaintained in antibiotic-free L-15
or antibiotic-free MEM respectively. The cells were transfected with
siRNAs using Lipofectamine™RNAiMAX (Invitrogen, Carlsbad, CA,
USA) by the reverse transfection method according to the manufac-
turer's instruction. Brieﬂy, 500 pmol of siPHB1_3 or siGFP were
incubated with 2.5 μl of Lipofectamine™RNAiMAX in 12-well tissue
culture plate for 20 min. Then 6×105 cells of CCL-125 or C6/36 were
seeded into the wells and samples incubated under standard
conditions. At 24 h post-transfection, the culture medium waschanged and the cells were further cultured for up to 5 days. Mock
transfections (lipofectamine only) were undertaken in parallel.RNA extraction and RT-PCR analysis
The transfected cells were harvested every day for 5 days and total
RNA extracted. The cells in each well were homogenized and incubated
with 1 ml of Tri reagent (Molecular Research Center, Cincinnati, OH) at
room temperature for 5 min. The mixture was vigorously vortexed in
the presence of 200 μl chloroform and allowed to stand at room
temperature for 15 min, followed by centrifugation at 12,000×g for
15 min. The aqueous phase solution was transferred to a new tube and
RNA precipitated with the addition of 500 μl of isopropanol at−30 °C
overnight. The solutionwas centrifuged at 12,000×g for 15 min and the
RNA pellets were washed with 75% ethanol with subsequent centrifu-
gation at 7500×g for 5 min. The pelletswere brieﬂy air-dried andﬁnally
dissolved in DEPC-treated water. Total RNA concentrations were
determined by spectrophotometry. For RT-PCR analysis, ﬁrst strand
cDNAwas synthesized using an oligo(dT)17 primer. The cDNAwas then
ampliﬁed in multiplex reactions with 2 speciﬁc primers for PHB1
(PHB1_F: 5′-TCACgCTgCgTATTCTgTTC-3′; PHB1_R: 5′-CTgTTgAgC-
gACCTgTTTCA-3′), and PHB2 (PHB2_F: 5′-AgAgTgTggTggCCAAgTTC-
3′; PHB2_R: 5′-TCTgCTgACgTTCCTgTTTg-3′). The expected products
were 305 bp for PHB1 and 246 bp for PHB2. The cycle conditions were
94 °C for 5 min, followed by 22 cycles of 94 °C for 20 s, 60 °C for 10 s and
72 °C for 10 s, followed by a ﬁnal extension of 72 °C for 5 min. The PCR
products were analyzed on 2% agarose gels.Infection assay, Western blot assay and VOPBA on PHB silenced cells
CCL-125 and C6/36 cells were mock transfected or transfected with
500 pmol of siPHB1_3 or siGFP as described above. On day 4 post-
transfection, cells were infected with DENV-2 at MOI of 10 for CCL-125
or at MOI of 1 for C6/36 at 28 °C for 2 h. The cells were washed with 1×
PBS and treated with acid glycine, pH 3 for 1 min to remove
uninternalized virus (Hung et al., 1999). Cells were washed with 1×
PBS again and fresh growth medium was added. After one and a half
virus replication cycles of each cell type (Sakoonwatanyoo et al., 2006;
Wikan et al., 2009), the culturemediumwas collected and the viral titer
was determined by standard plaque assay (Sithisarn et al., 2003). Each
sample was analyzed in duplicate and the experiment was done
independently in triplicate. The transfected-infected cells were collect-
ed for protein extraction and Western blot assay and VOPBA as
described above.Antibody mediated infection inhibition assay
CCL-125 and C6/36 cells were grown in six-well plates and the cells
were then incubated with a rabbit polyclonal antibody against PHB2 at
various concentration or a polyclonal antibodyagainst STAT5 (sc-28685,
Santa Cruz Biotechnology) or no antibody at 28 °C for 1 h. After
incubation, the cells were infected with DENV-2 at MOI of 10 for CCL-
125 or atMOI of 1 for C6/36 at 28 °C for 2 h. The cells werewashedwith
1× PBS and treated with acid glycine, pH 3 for 1 min to remove
uninternalized virus (Hung et al., 1999). The cells were washedwith 1×
PBS and fresh growth medium was added. The culture medium was
collected after one and a half virus replication cycle of each cell type
(Sakoonwatanyoo et al., 2006;Wikan et al., 2009) for viral titration and
the cells were collected for intracellular virus assay. The intracellular
viruses were released from the cell by one freeze–thaw cycle followed
by sonication at 4 °C for 5 min (Thepparit and Smith, 2004) and viral
titer was determined by standard plaque assay (Sithisarn et al., 2003).
Each sample was analyzed in duplicate and the experiment was done
independently in triplicate.
160 A. Kuadkitkan et al. / Virology 406 (2010) 149–161Infection inhibition assay by ﬂow cytometry
C6/36 cells were grown on six-well plates under standard
conditions for 24 h; the cells were then incubated with 20 μg of an
antibody directed against PHB2 (sc-67045, Santa Cruz Biotechnology)
or 20 μg of an antibody directed against STAT5 (sc-28685, Santa Cruz
Biotechnology) or 20 μg of antibody directed against integrin αV/β5
(sc-13588 Santa Cruz Biotechnology) or no antibody at 28 °C for 1 h.
After incubation, the cells were infected with DENV-2 or JEV at MOI of
10 at 28 °C for 2 h. The cells were washed with 1× PBS and treated
with acid glycine pH 3 for 1 min to remove the excess virus. The cells
were further cultured at standard condition for 15 h for a JEV infected
cell or 16 h for a DENV-2 infected cell. Then the cells were harvested
by scraping and ﬁxed in 4% paraformaldehyde in 1× PBS for 20 min at
room temperature. Cells were subsequently washed twice with 1%
BSA in PBS and permeabilized with 0.2% saponin. The cells were
incubated with a 1:10 dilution of a pan speciﬁc anti-dengue virus E
protein monoclonal antibody (HB114) or 1:10 dilution of a monoclo-
nal anti-ﬂavivirus antibody (HB112, Henchal et al., 1985). After
washing, the cells were incubated with a 1:10 dilution of a goat anti-
mouse IgG conjugated with ﬂuorescein for 1 h at room temperature.
Then the cells were analyzed by ﬂow cytometry (BD FACalibur).
Analysis of cell surface binding of DENV-2
C6/36 cells were grown on 12-mm coverslips (Menzel-Glaser,
Braunschweig, Germany) at 28 °C for 1 day. Cells were subsequently
washed twice with PBS followed by ﬁxation with 4% paraformalde-
hyde for 15 min. After washing twice with PBS, cells were incubated
with or without 15 μg of a rabbit polyclonal antibody directed against
PHB2 (sc-67045, Santa Cruz Biotechnology Inc.) at 4 °C for 1 h. After
incubation, cells were washed twice with PBS, and then approxi-
mately 2×107 pfu DENV-2 per coverslip was added and samples were
incubated at 4 °C for 1 h. The excess unbound viruses were removed
by washing twice with PBS followed by ﬁxation with 4% paraformal-
dehyde for 15 min. After a further twowasheswith PBS, the cells were
incubated for 90 min at 4 °C with a 1:10 dilution of pan speciﬁc anti-
dengue virus monoclonal antibody produced by hybridoma cell line
HB114 (Henchal et al., 1985). The coverslips were washed twice with
PBS and subsequently incubated for 30 min at 4 °C with a 1:10
dilution of a goat anti-mouse IgG antibody labeled with ﬂuorescein
isothiocyanate (FITC; KPL, Gaithersburg, MD, USA) followed by a
further two washes with PBS. Signals were observed under an
Olympus ﬂuorescence microscope.
Immunoﬂuorescence
C6/36 cells were seeded on glass coverslips and cultured under
standard condition for 24 h, and then the cellswere infectedwithDENV-
2 at MOI of 1. After 24 h post-infection, the cells were washed with PBS
and ﬁxed with 100% pre-cooled methanol for 20 min. The cells were
subsequently permeabilized with 0.3% Triton X-100 in PBS for 10 min
and then washed twice with 0.03% Triton X-100 in PBS. The cells were
then incubatedwith a 1:10 dilution of a pan speciﬁc anti-dengue virus E
protein monoclonal antibody (HB114) and a 1:100 dilution of a goat
polyclonal anti-PHB1 antibody or a 1:100 dilution of a rabbit polyclonal
anti-PHB2 antibody (sc-67045, Santa Cruz Biotechnology Inc.) at 4 °C
overnight. After primary antibody incubation, the cells were washed
four timeswith 0.03% TritonX-100 in PBS and incubatedwith secondary
antibody for 1 h at room temperature. Subsequently the cells were
washed six times with 0.03% Triton X-100 in PBS and then mounted
onto glass slides. The cells were observed under a confocal microscope
(Olympus FluoView 1000). The secondary antibodies used were 1:10
dilution of a ﬂuorescein isothiocyanate (FITC)-conjugated goat anti-
mouse IgG (KPL), a 1:100 dilution of a Cy5-conjugated rabbit anti-goatIgG (Invitrogen) and a 1:100 dilution of a Rhodamine Red X-conjugated
goat anti-rabbit IgG (Jackson ImmunoResearch).
Coimmunoprecipitation
C6/36 cells were grown in 10-mm tissue culture plates. The cells
were infected with DENV-2 at MOI of 10 at 28 °C for 2 h or mock
infected. At day 3 post-infection, the culture medium was discarded
and the cells werewashed twice with cooled-PBS and then lysis buffer
(20 mM Tris–HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100,
2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM
Na3VO4, 1 mM PMSF) was added. The lysed cells were collected by
scraping and solutions centrifuged at 14,000×g for 10 min at 4 °C. The
lysates were transferred to new tubes and kept at −80 °C until use.
200 μl of lysates were incubated with 20 μl of a 50% slurry of protein G
sepharose beads (Protein G Sepharose™ 4 Fast Flow, Amersham
Bioscience, NJ, USA) with gentle rocking at 4 °C for 1 h. The mixture
was centrifuged at 6000×g for 3 min and the supernatant was
transferred to a new tube, then 1 μg of a rabbit polyclonal anti-PHB2
antibody (sc-67045, Santa Cruz Biotechnology Inc.) was added. The
mixture was incubated with gentle agitation overnight at 4 °C,
following which a further 20 μl of 50% slurry of protein G sepharose
beads was added and samples incubated at 4 °C for 3 h. After
centrifugation, the supernatant was discarded and the pellet was
washed twice with 1× lysis buffer and resuspended with 20 μl of 3×
SDS sample buffer and heated at 100 °C for 5 min and then centrifuged
at 14,000×g for 2 min. The presence of DENV-2 E protein was
detected by Western blotting as described above using a 1:200
dilution of a mouse anti-dengue complex monoclonal antibody
(MAB8705, Millipore, MA, USA) followed by a 1:8000 dilution of a
horseradish peroxidase-conjugated rabbit anti-mouse IgG secondary
antibody (Sigma).
Statistical analysis
Viral production data were analyzed using the GraphPad Prism
program (GrapPad Software). Statistical analysis of signiﬁcance was
done by a paired sample test using SPSS (SPSS Inc., Chicago, IL) using a
value of Pb0.05 for signiﬁcance.
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